Yuchuan Yan

发表

TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB‐EGF Expression and Proteolytic Cleavage

W. Zhou, Zhiqiang Chen, Dong Sun, 2019, Hepatology.

Peripheral cytokine levels as novel predictors of survival in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

X. Mao, Tao Li, Lun-Jie Yan, 2022, Frontiers in Immunology.

Hepatitis B virus reactivation in patients undergoing immune checkpoint inhibition: systematic review with meta-analysis

Jingling Xue, Zhiqiang Chen, Jianguo Hong, 2022, Journal of Cancer Research and Clinical Oncology.

Effect of ARID1A mutation and expression on prognosis of hepatocellular carcinoma and cholangiocarcinoma: a meta-analysis

Zhiqiang Chen, Tao Li, Lun-Jie Yan, 2020 .

Role of the E3 Ubiquitin Ligase TRIM4 in Predicting the Prognosis of Hepatocellular Carcinoma

W. Zhou, Dong Sun, Xu-ting Zhi, 2020, Journal of Cancer.

Adverse events of immune checkpoint inhibitors in hepatocellular carcinoma: a systemic review and meta-analysis

Jingling Xue, C. Han, Tao Li, 2022, Clinical and Experimental Medicine.

Evaluating liver function and the impact of immune checkpoint inhibitors in the prognosis of hepatocellular carcinoma patients: A systemic review and meta-analysis.

Jingling Xue, Zhiqiang Chen, Jianguo Hong, 2022, International immunopharmacology.

Somatic mutation and expression of BAP1 in hepatocellular carcinoma: an indicator for ferroptosis and immune checkpoint inhibitor therapies

Zhiqiang Chen, Jianguo Hong, Tao Li, 2022, Journal of Cancer.

RECK expression is associated with angiogenesis and immunogenic Tumor Microenvironment in Hepatocellular Carcinoma, and is a prognostic factor for better survival

Zhiqiang Chen, Xu-ting Zhi, Tao Li, 2021, Journal of Cancer.

Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis

Zhiqiang Chen, Tao Li, Lun-Jie Yan, 2021, Journal of gastroenterology and hepatology.

Clinical Benefit of Antiviral Agents for Hepatocellular Carcinoma Patients With Low Preoperative HBV-DNA Loads Undergoing Curative Resection: A Meta-Analysis

Jianguo Hong, Xu-ting Zhi, Tao Li, 2021, Frontiers in Oncology.

Hepatic metastatic paraganglioma 12 years after retroperitoneal paraganglioma resection: a case report

Tao Li, Lun-Jie Yan, Zhao-Ru Dong, 2019, BMC Gastroenterology.

A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response

Jingling Xue, Jianguo Hong, C. Han, 2023, Frontiers in Pharmacology.

Efficacy and safety of immune checkpoint inhibitors for hepatocellular carcinoma patients with macrovascular invasion or extrahepatic spread: a systematic review and meta-analysis of 54 studies with 6187 hepatocellular carcinoma patients

Jingling Xue, Tao Li, Zhiqiang Chen, 2023, Cancer Immunology, Immunotherapy.

Viral Status and Efficacy of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis

Zhiqiang Chen, Jianguo Hong, Tao Li, 2021, Frontiers in Immunology.

Systematic Therapy With or Without Locoregional Therapy for Advanced Hepatocellular Carcinoma: A Systematic Review and Network Meta-analysis.

Rui Li, Jingling Xue, Tao Li, 2023, Critical reviews in oncology/hematology.

Anthropometric indicators of adiposity and risk of primary liver cancer: A systematic review and dose-response meta-analysis.

Tao Li, Lun-Jie Yan, Zhao-Ru Dong, 2023, European journal of cancer.

The somatic mutational landscape and role of the ARID1A gene in hepatocellular carcinoma

Zhiqiang Chen, Jianguo Hong, Tao Li, 2023, Heliyon.

Efficacy and security of tumor vaccines for hepatocellular carcinoma: a systemic review and meta-analysis of the last 2 decades

Zhiqiang Chen, Jianguo Hong, C. Han, 2022, Journal of Cancer Research and Clinical Oncology.

Identification of the most effective subgroup of advanced hepatocellular carcinoma from immune checkpoint blocker treatment: a meta-analysis.

Jingling Xue, Zhiqiang Chen, Jianguo Hong, 2023, Immunotherapy.

NAD+ salvage governs mitochondrial metabolism, invigorating natural killer cell antitumor immunity

K. Yamagata, Xuetian Yue, Zhuanchang Wu, 2022, Hepatology.

Effect of liver metastasis on the efficacy of immune checkpoint inhibitors in cancer patients: a systemic review and meta-analysis

Jingling Xue, Tao Li, C. Han, 2023, Clinical & Experimental Metastasis.

Caffeine intake is associated with less severe depressive symptoms in noncancer populations: an analysis based on NHANES 2007-2016.

Tao Li, Zhao-Ru Dong, Yuchuan Yan, 2023, Nutrition research.

Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity

Tao Li, Zhao-Ru Dong, Guangju Meng, 2023, Cell death & disease.

Effects of hypoxia‐inducible factor‐1α and hypoxia‐inducible factor‐2α overexpression on hepatocellular carcinoma survival: A systematic review with meta‐analysis

Zhiqiang Chen, Tao Li, Zhao-Ru Dong, 2021, Journal of Gastroenterology and Hepatology.

A model based on adipose and muscle-related indicators evaluated by CT images for predicting microvascular invasion in HCC patients

C. Han, Tao Li, Zhao-Ru Dong, 2023, Biomarker Research.

Performance of GALAD score and serum biomarkers for detecting NAFLD-related HCC: a systematic review and network meta-analysis

C. Han, Tao Li, Zhao-Ru Dong, 2023, Expert review of gastroenterology & hepatology.

MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway

Rui Li, Jianguo Hong, Tao Li, 2023, Cancer Cell International.

Safety, efficacy, and survival outcomes of immune checkpoint inhibitors rechallenge in patients with cancer: a systematic review and meta-analysis.

C. Han, Zhao-Ru Dong, Hui Liu, 2024, The oncologist.

Role of hepatitis B core-related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta-analysis.

C. Han, Zhao-Ru Dong, Hui Liu, 2024, Journal of gastroenterology and hepatology.

Salvage surgery after combination immunotherapy for initially unresectable or metastastic hepatocellular carcinoma: A retrospective clinical study

Zhiqiang Chen, Jianguo Hong, Tao Li, 2023, Clinical Surgical Oncology.

Construction of an anoikis‒related prognostic signature to predict immunotherapeutic response and prognosis in hepatocellular carcinoma

Rui Li, Tao Li, Zhaoru Dong, 2023, Journal of Cancer Research and Clinical Oncology.